What is Omada?
Founded in 2011 and headquartered in San Francisco, Omada Health is a digital behavioral medicine company. It offers a personalized, evidence-based behavior change program that provides virtual support across the chronic disease spectrum for populations. The company leverages technology to deliver scalable and effective interventions for chronic condition management, aiming to improve health outcomes and reduce healthcare costs.
How much funding has Omada raised?
Omada has raised a total of $678.3M across 10 funding rounds:
Series C
$48M
Series D
$50M
Other Financing Round
$73M
Corporate Investment
$57M
Series E
$192M
Debt
$80M
IPO
$150M
Series C (2015): $48M featuring Norwest Venture Partners, Andreessen Horowitz, dRx Capital, Providence, U.S. Venture Partners, GE Ventures, Rock Health companies, and Humana Inc.
Series D (2017): $50M backed by Cigna, Sanofi-Genzyme BioVentures, and Civilization Ventures
Other Financing Round (2019): $73M, investors not publicly disclosed
Corporate Investment (2020): $57M led by Perceptive Advisors
Series E (2022): $192M supported by Perceptive Advisors, Fidelity Investments, Civilization Ventures, Wellington Management, and aMoon
Debt (2023): $80M featuring MidCap Financial
IPO (2025): $150M, investors not publicly disclosed
Key Investors in Omada
Cigna
Cigna is a global health company dedicated to improving health and vitality through innovative solutions. Their investment in Omada Health aligns with their mission to provide comprehensive health services and support for individuals managing chronic conditions.
New Enterprise Associates
New Enterprise Associates (NEA) is a prominent venture capital firm focused on empowering entrepreneurs to build transformative businesses. Their investment in Omada Health reflects a belief in the company's potential to disrupt the digital health landscape.
U.S. Venture Partners
U.S. Venture Partners (USVP) is a venture capital firm that partners with entrepreneurs to build leading companies, particularly in early-stage technology and healthcare. Their backing of Omada Health highlights the company's innovative approach to digital behavioral medicine.
What's next for Omada?
With substantial backing, Omada Health is poised for further scaling and innovation in the digital therapeutics market. The company's focus on chronic disease management, combined with its established track record, suggests a strategic direction towards expanding its program offerings, enhancing its technological platform, and potentially pursuing new market segments or partnerships. Future growth will likely involve deepening its integration with healthcare systems and payers, further solidifying its role in value-based care.
See full Omada company page
